Blood Profiling Atlas in Cancer (BloodPAC)
A warm welcome to our newest member, SiO2 Material Science ! SiO2 Material Science is committed to advancing #liquidbiopsy research with a proprietary Blood Collection Tube (BCT) using Plasma Enhanced..
SiO2 Scales Manufacturing of Hybrid Vial Capacity for 400 Million Doses of COVID-19 Vaccine Achieved Ahead of Schedule
AUBURN, Ala., July 2, 2020 /PRNewswire/ -- SiO2 Materials Science, a privately-owned US-based advanced materials science company, today announced they have successfully scaled their
SiO2 Materials Science receives $143 million contract from U.S. Government
AUBURN, AL, June 8, 2020- SiO2 Materials Science, a privately-owned U.S. advanced materials science corporation introducing breakthrough disruptive technology for packaging biological pharmaceuticals
SiO2 Materials Sciences launches a line of specialty vials for biological drugs and vaccines
AUBURN, Ala. (PRWEB) April 29, 2020 SiO2 Materials Sciences launches a line of specialty vials for biological drugs and vaccines. The SiO2 vials solve significant challenges in the commercialization
SiO2 Materials Science launches new vials as the ideal alternative to glass
Auburn, Alabama, April 2020 – SiO2 Materials Science today announced the launch of a line of glassalternative vials for use in vaccines, biological drugs, and cell & gene therapy primary packaging.
SIO2 Materials Science launches new organization to attend to customer demands
Auburn, Alabama, January 2020 – SiO2 Materials Science today announced that it has launched a new commercial organization to take the company to new heights.
SiO2 Materials Science launches first ever blood collection tube for cfDNA/cfRNA & gDNA/RNA pairing
AUBURN, Ala., Dec. 3, 2019 /PRNewswire/ -- SiO2 Materials Science is thrilled to launch the Synergy Tube, a proprietary Blood Collection Tube, as the company's first Genetic
PRESS RELEASE: SIO2 Medical Products rebrands as SIO2 Materials Science
Auburn, Alabama, November, 2019 – SiO2 Medical Products today announced that it has changed its name and brand to SIO2 Materials Science.
PRESS RELEASE: A leading global medicines company executes a strategic investment in SiO2 Medical Products gaining access to a potentially
AUBURN, Alabama, Nov. 19, 2019 /PRNewswire/ -- SiO2 Medical Products today announced a strategic investment by Novartis to explore and potentially use its materials sciences